关键词: Cervus nippon mantchuricus Extract Cyclophosphamide (PubChem CID: 2907) Deer bone Immune-enhancing activity Immunosuppressed mice Lipopolysaccharide (PubChem CID: 11970143) MAPK Macrophages NF-κB

Mesh : Animals Blotting, Western Bone and Bones / immunology Cell Culture Techniques Cell Differentiation / drug effects immunology Cell Survival / drug effects immunology Cytokines / drug effects immunology Deer Enzyme-Linked Immunosorbent Assay Immunologic Factors / immunology Immunosuppression Therapy Macrophages / drug effects immunology Male Medicine, Korean Traditional / methods Mice Mice, Inbred BALB C Mitogen-Activated Protein Kinases / drug effects immunology Models, Animal NF-kappa B / drug effects immunology Nitric Oxide / immunology RAW 264.7 Cells Signal Transduction / drug effects immunology Tissue Extracts / immunology

来  源:   DOI:10.1016/j.foodres.2017.06.053   PDF(Sci-hub)

Abstract:
Chemotherapeutics are often used to inhibit the proliferation of cancer cells. However, they can also harm healthy cells and cause side effects such as immunosuppression. Especially traditional oriental medicines long used in Asia, may be beneficial candidates for the alleviation of immune diseases. Cervus nippon mantchuricus extract (NGE) is currently sold in the market as coffee and health drinks. However, NGE was not widely investigated and efficacy remain unclear and essentially nothing is known about their potential immune-regulatory properties. As a result, NGE induced the differentiation of RAW264.7 macrophage cells. NGE-stimulated RAW264.7 macrophage cells elevated cytokines levels and NO production. NGE-stimulated RAW264.7 macrophage cells activated MAPKs and NF-κB signaling pathways. NGE encouraged the immuno-enhancing effects in immunosuppressed short-term treated with NGE mice model. NGE or Red ginseng encouraged the immuno-enhancing effects in immunosuppressed long-term treated with NGE mice model. Our data clearly show that NGE contains immune-enhancing activity and can be used to treat immunodeficiency.
摘要:
暂无翻译
公众号